|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61F 13/00 | (2006.01) |
| A61K 31/485 | (2006.01) | ||
| A61K 9/70 | (2006.01) | ||
| A61P 25/04 | (2006.01) |
| (11) | Number of the document | 2305194 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10185240.8 |
| Date of filing the European patent application | 1998-02-24 | |
| (97) | Date of publication of the European application | 2011-04-06 |
| (45) | Date of publication and mention of the grant of the patent | 2012-05-09 |
| (46) | Date of publication of the claims translation | 2012-08-27 |
| (30) | Number | Date | Country code |
| 38919 P | 1997-02-24 | US | |
| 939068 | 1997-09-29 | US |
| (72) |
Reder, Robert, F., US
Goldenheim, Paul, D., US
Kaiko, Robert, F., US
|
| (73) |
EURO-CELTIQUE S.A.,
2, avenue Charles de Gaulle, 1653 Luxembourg,
LU
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Buprenorfino transderminis rinkinys, skirtas panaudoti gydant skausmą mažiausiai 7 dienų dozavimo intervalu |
| A buprenorphine transdermal patch for use in the treatment of pain for a dosing interval of at least 7 days |
| Payment date | Validity (years) | Amount | |
| 2017-01-18 | 20 | 347.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2017-07-25 |